The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hyrnuo (sevabertinib) for adults with locally ...

The FDA has withdrawn its accelerated approval of Krazati (adagrasib) combined with Erbitux (cetuximab) for adults with KRAS G12C-mutated colorectal cancer that is locally advanced or has spread to ...

Please check back later for more content.

CURE ® readers have a unique opportunity each year to honor oncology nurses who have helped guide them through the cancer experience. Many thoughtful nomination essays are prepared and submitted by ...

Please check back later for more content.

Explore how personalized treatment, immunotherapy, AI and other advances are transforming cancer care, with insights from Dr. Manmeet Ahluwalia.

Two and a half years into cancer treatment, my nurse Jenny Gnoza still greets me with a smile, steadies my nerves and finds the vein everyone else misses.

For patients receiving chemotherapy for aggressive lymphoma, we may see lower blood counts, which can increase the risk of infection. Some patients may need blood or platelet transfusions. Hair loss ...

Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.

My multiple myeloma nurse case manager sat in on every appointment, helped me appeal an insurance denial and made sure I never felt like just a number.

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb on "Investigating Myeloma," a disease awareness ...

Please check back later for more content.